⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
TENX News
Tenax Therapeutics, Inc.
Tenax Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
TENX
Form 8-K
sec.gov
TENX
Tenax Therapeutics Announces Late-Breaking Presentation of LEVEL Clinical Trial Data at ESC Congress 2026
globenewswire.com
TENX
Form 8-K
sec.gov
TENX
Form 8-K
sec.gov
TENX
Form 8-K
sec.gov
TENX
Form 8-K
sec.gov
TENX
Tenax Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update
globenewswire.com
TENX
Tenax Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
TENX
Tenax Therapeutics Appoints Timothy Healey, MBA as Chief Commercial Officer
globenewswire.com
TENX